1. Caputo V, Cianetti L, Niceta M, Carta C, Ciolfi A, Bocchinfuso G, Carrani E, Dentici Maria L, Biamino E, Belligni E, Garavelli L, Boccone L, Melis D, Andria G, Gelb Bruce D, Stella L, Silengo M, Dallapiccola B.Tartaglia M. A restricted spectrum of mutations in the smad4 tumor-suppressor gene underlies myhre syndrome. The American Journal of Human Genetics. 2012; 90(1):161-169.
2. Caputo V, Bocchinfuso G, Castori M, Traversa A, Pizzuti A, Stella L, Grammatico P.Tartaglia M. Novelsmad4mutation causing myhre syndrome. American Journal of Medical Genetics Part A. 2014;164(7):1835-1840.
3. Myhre S A, Ruvalcaba R H.Graham C B. A new growth deficiency syndrome. Clin. Genet.(1981; 20(1): 1-5.
4. Le Goff C, Mahaut C, Abhyankar A, Le Goff W, Serre V, Afenjar A, Destrée A, di Rocco M, Héron D, Jacquemont S, Marlin S, Simon M, Tolmie J, Verloes A, Casanova J-L, Munnich A.Cormier-Daire V. Mutations at a single codon in mad homology 2 domain of smad4 cause myhre syndrome. Nat Genet.2011; 44(1):85-88.
5. Al Ageeli E, Mignot C, Afenjar A, Whalen S, Dorison N, Mayer M, Esteva B, Dubern B, Momtchilova M, Le Gargasson J F, Bursztyn J.Heron D. Retinal involvement in two unrelated patients with myhre syndrome. Eur J Med Genet.2012;55(10): 541-547.
6. Asakura Y, Muroya K, Sato T, Kurosawa K, Nishimura G.Adachi M. First case of a japanese girl with myhre syndrome due to a heterozygous smad4 mutation. Am J Med Genet A. 2012;158A(8):1982-1986.
7. Lindor N M, Gunawardena S R.Thibodeau S N.. Mutations of smad4 account for both laps and myhre syndromes. Am J Med Genet A. 2012;158A(6): 1520-1521.
8. Picco P, Naselli A, Pala G, Marsciani A, Buoncompagni A.Martini A. Recurrent pericarditis in myhre syndrome. Am J Med Genet A. 2013; 161A(5):1164-1166.
9. Ishibashi N, Sasaki Y.Asakura Y. Myhre syndrome: A rare craniofacial disorder. Cranio. 2014; 32(4): 300-306.
10. Kenis C, Verstreken M, Gieraerts K, De Foer B, Van der Aa N, Offeciers E F.Casselman J W. Bilateral otospongiosis and a unilateral vestibular schwannoma in a patient with myhre syndrome. Otol Neurotol. 2014; 35(9):e253-255.
11. Michot C, Le Goff C, Mahaut C, Afenjar A, Brooks A S, Campeau P M, Destree A, Di Rocco M, Donnai D, Hennekam R, Heron D, Jacquemont S, Kannu P, Lin A E, Manouvrier-Hanu S, Mansour S, Marlin S, McGowan R, Murphy H, Raas-Rothschild A, Rio M, Simon M, Stolte-Dijkstra I, Stone J R, Sznajer Y, Tolmie J, Touraine R, van den Ende J, Van der Aa N, van Essen T, Verloes A, Munnich A.Cormier-Daire V.. Myhre and laps syndromes: Clinical and molecular review of 32 patients. Eur J Hum Genet. 2014; 22(11):1272-1277.
12. Hawkes L.Kini U.. Myhre syndrome with facial paralysis and branch pulmonary stenosis. Clin Dysmorphol. 2015,4(2): 84-85.
13. Oldenburg M S, Frisch C D, Lindor N M, Edell E S, Kasperbauer J L.O'Brien E K. Myhre-laps syndrome and intubation related airway stenosis: Keys to diagnosis and critical therapeutic interventions. Am J Otolaryngol. 2015;36(5): 636-641.
14. Starr L J, Grange D K, Delaney J W, Yetman A T, Hammel J M, Sanmann J N, Perry D A, Schaefer G B.Olney A H. Myhre syndrome: Clinical features and restrictive cardiopulmonary complications. Am J Med Genet A. 2015;167A(12): 2893-2901.
15. Bassett J K, Douzgou S.Kerr B. Severe constipation in a patient with myhre syndrome: A case report. Clin Dysmorphol. 2016; 25(2): 54-57.
16. Lin A E, Michot C, Cormier-Daire V, L'Ecuyer T J, Matherne G P, Barnes B H, Humberson J B, Edmondson A C, Zackai E, O'Connor M J, Kaplan J D, Ebeid M R, Krier J, Krieg E, Ghoshhajra B.Lindsay M E. Gain-of-function mutations in smad4 cause a distinctive repertoire of cardiovascular phenotypes in patients with myhre syndrome. Am J Med Genet A. 2016; 170(10):2617-2631.
17. Burglen L, Heron D, Moerman A, Dieux-Coeslier A, Bourguignon J P, Bachy A, Carel J C, Cormier-Daire V, Manouvrier S.Verloes A. Myhre syndrome: New reports, review, and differential diagnosis. J Med Genet. 2003; 40(7): 546-551.
18. Becerra-Solano L E, Diaz-Rodriguez M, Nastasi-Catanese J A, Toscano-Flores J J, Banuelos-Robles O, Figuera L E, Matute E.de Lourdes Ramirez-Duenas M. The fifth female patient with myhre syndrome: Further delineation. Clin Dysmorphol. 2008; 17(2):113-117.
19. Allali S, Le Goff C, Pressac-Diebold I, Pfennig G, Mahaut C, Dagoneau N, Alanay Y, Brady A F, Crow Y J, Devriendt K, Drouin-Garraud V, Flori E, Genevieve D, Hennekam R C, Hurst J, Krakow D, Le Merrer M, Lichtenbelt K D, Lynch S A, Lyonnet S, MacDermot K, Mansour S, Megarbane A, Santos H G, Splitt M, Superti-Furga A, Unger S, Williams D, Munnich A.Cormier-Daire V. Molecular screening of adamtsl2 gene in 33 patients reveals the genetic heterogeneity of geleophysic dysplasia. J Med Genet. 2011;48(6): 417-421.
20. Faivre L, Gorlin R J, Wirtz M K, Godfrey M, Dagoneau N, Samples J R, Le Merrer M, Collod-Beroud G, Boileau C, Munnich A.Cormier-Daire V. In frame fibrillin-1 gene deletion in autosomal dominant weill-marchesani syndrome. J Med Genet. 2003;40(1):34-36.
21. Dagoneau N, Benoist-Lasselin C, Huber C, Faivre L, Megarbane A, Alswaid A, Dollfus H, Alembik Y, Munnich A, Legeai-Mallet L.Cormier-Daire V. Adamts10 mutations in autosomal recessive weill-marchesani syndrome. Am J Hum Genet. 2004;75(5): 801-806.
22. Le Goff C, Morice-Picard F, Dagoneau N, Wang L W, Perrot C, Crow Y J, Bauer F, Flori E, Prost-Squarcioni C, Krakow D, Ge G, Greenspan D S, Bonnet D, Le Merrer M, Munnich A, Apte S S.Cormier-Daire V. Adamtsl2 mutations in geleophysic dysplasia demonstrate a role for adamts-like proteins in tgf-beta bioavailability regulation. Nat Genet. 2008; 40(9): 1119-1123.
23. Piccolo P, Mithbaokar P, Sabatino V, Tolmie J, Melis D, Schiaffino M C, Filocamo M, Andria G.Brunetti-Pierri N. Smad4 mutations causing myhre syndrome result in disorganization of extracellular matrix improved by losartan. Eur J Hum Genet. 2014; 22(8): 988-994.
24. Zhang J, Tan X, Li W, Wang Y, Wang J, Cheng X.Yang X. Smad4 is required for the normal organization of the cartilage growth plate. Dev. Biol. 2005; 284(2): 311-322.
25. Yang S-M, Hou Z-H, Yang G, Zhang J-S, Hu Y-Y, Sun J-H, Guo W-W, He D z z, Han D-Y, Young W-Y.Yang X. Chondrocyte-specificsmad4gene conditional knockout results in hearing loss and inner ear malformation in mice. Dev Dyn. 2009;238(8): 1897-1908.
26. Kuroda S.Houkin K. Moyamoya disease: Current concepts and future perspectives. Lancet Neurol. 2008; 7(11):1056-1066.
27. Weng L, Cao X, Han L, Zhao H, Qiu S, Yan Y, Wang X, Chen X, Zheng W, Xu X, Gao Y, Chen Y, Li J, Yang Y.Xu Y. Association of increased treg and th17 with pathogenesis of moyamoya disease. Sci Rep. 2017;7(1): 3071.
28. Sachin G, Kusum J, Wig JD, Arora SK: Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis. Acta Oncol 2007, 46(6):792-797.
29. Shigeyuki S, Yoshihiro K, Fumiyuki Y, Masaaki S, Shinji O, Prabin S, Kazuhiko S, Kaoru K: Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease. Neurosurg Rev 2008, 31(1):77.